Furthermore, in a randomized, double-blind, and placebo-controlled clinical trial, it was shown that vitamin D supplementation significantly improved the levels of Aβ-42, APP, and BACE1 in elderly patients with AD (224). The gene discussed is BACE1; the disease is Alzheimer disease.